What does Rebus Holdings, Inc. do?

Rebus Holdings, Inc. (RBSH) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is RBSH's market cap?

Rebus Holdings, Inc. (RBSH) has a market capitalization of approximately $3,213, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does RBSH pay a dividend?

No — Rebus Holdings, Inc. (RBSH) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

RBSH

Rebus Holdings, Inc.

OTC·Biotechnology · Healthcare

$0.00$0.00+0.00%

Market cap$3.21K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−99.96%CAGR −79.17%

Select date range

FromTo

Nov 4, 2009Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

RBSH does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateNov 26

Last Report DateJun 29

Reported vs Estimate$0.00

Earnings Surprise—

FinancialsFinancials Tab

Revenue$0.00

Net Income$570.00K

Net Margin—

Operating Cash Flow−$528.00K

Capital Expenditures$0.00

Free Cash Flow−$528.00K

Return on Equity—

Return on Invested Capital2.1%

Net Debt$305.00K

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for RBSH and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how RBSH's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for RBSH and 80,000+ other tickers.

About Rebus Holdings, Inc.

Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for oncology. Its flagship investigational product, RT-AR001, operates as an adenosine receptor antagonist. This compound, when administered directly into cancerous growths, is engineered to diminish tumor invasion and improve therapeutic efficacy. The corporation was established in 2003 and maintains its headquarters in Westlake Village, California.

CEO: Raul Silvestre
Sector: Healthcare
Industry: Biotechnology
Exchange: OTC
Employees: 1
Website: www.rebus-corp.com

Peers

Peers Tab

SNNAQ

Sienna Biopharmaceuticals, Inc.

Cap

$3.1K

CMRA

Comera Life Sciences Holdings, Inc.

Cap

$3.1K

SYVC

Synovics Pharmaceuticals, Inc.

Cap

$3.0K

Latest News

News Tab

No recent news available.

Frequently Asked Questions About RBSH

What does Rebus Holdings, Inc. do?: Rebus Holdings, Inc. (RBSH) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is RBSH's market cap?: Rebus Holdings, Inc. (RBSH) has a market capitalization of approximately $3,213, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does RBSH pay a dividend?: No — Rebus Holdings, Inc. (RBSH) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.